Clinicians at Georgetown University s Lombardi Comprehensive Cancer Center reported promising preliminary findings based on outcomes in the first six patients with metastatic pancreatic cancer enrolled in a Phase II clinical trial of the experimental drug BXCL701 in combination with the immunotherapy drug pembrolizumab (Keytruda). Immunotherapy drugs alone have not shown to be responsive to pancreatic cancer.
Georgetown s Cancer Center Awarded Top Designation by National Cancer Institute; Comprehensive Cancer Center Consortium Includes Hackensack Meridian s John Theurer Cancer Center onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.
Spring is fast approaching! Prepare for Washington’s blooming social season with this gala guide featuring parties and events from late February through
georgetown.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from georgetown.edu Daily Mail and Mail on Sunday newspapers.